PreveCeutical Medical Inc. (OTCMKTS:PRVCF) Short Interest Update

PreveCeutical Medical Inc. (OTCMKTS:PRVCF) was the target of a significant decline in short interest during the month of February. As of February 15th, there was short interest totalling 21,300 shares, a decline of 61.3% from the January 31st total of 55,000 shares. Based on an average daily trading volume, of 154,800 shares, the short-interest ratio is currently 0.1 days.

PreveCeutical Medical Stock Performance

OTCMKTS PRVCF traded down $0.00 on Friday, hitting $0.02. 7,000 shares of the stock were exchanged, compared to its average volume of 156,182. The business’s fifty day moving average is $0.02 and its 200 day moving average is $0.02. PreveCeutical Medical has a 52 week low of $0.01 and a 52 week high of $0.03.

PreveCeutical Medical Company Profile

PreveCeutical Medical Inc, a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; Non-Addictive Analgesic for pain management; BSV Peptide Program that targets cancer progression; and Dual Gene Therapy for type 2 diabetes and obesity.